BBOTVSUSNA• 6 Months (Normalized)
BBOT vs USNA (BridgeBio Oncology Therapeutics Inc. vs USANA Health Sciences Inc.)
Showing Closing Date Range from Apr 9 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.6
-59.35%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
USNA Performance $14.85
+2.48%
USANA Health Sciences Inc.
Normalized Baseline0.00%
Alpha Spread Margin USNA LEADS
-61.83 pts
USNA outperforming by 61.83 percentage points
BBOTUSNA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT USNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | BBOT Price | BBOT Gain (%) | USNA Price | USNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $3.60 | -59.35% | $14.85 | +2.48% | -61.83% |
| Oct 02, 2026 | $3.89 | -56.07% | $14.82 | +2.28% | -58.35% |
| Sep 30, 2026 | $4.10 | -53.70% | $- | - | |
| Sep 29, 2026 | $3.92 | -55.73% | $14.70 | +1.45% | -57.18% |
| Sep 28, 2026 | $3.81 | -56.97% | $14.82 | +2.28% | -59.25% |
| Sep 25, 2026 | $3.95 | -55.39% | $14.50 | +0.07% | -55.46% |
| Sep 24, 2026 | $3.99 | -54.94% | $14.26 | -1.59% | -53.35% |
| Sep 23, 2026 | $4.16 | -53.02% | $14.04 | -3.11% | -49.91% |
| Sep 22, 2026 | $4.66 | -47.37% | $14.78 | +2.00% | -49.37% |
| Sep 21, 2026 | $4.66 | -47.37% | $14.49 | +0.00% | -47.37% |
| Sep 18, 2026 | $4.77 | -46.13% | $- | - | |
| Sep 17, 2026 | $4.89 | -44.78% | $- | - | |
| Sep 16, 2026 | $4.76 | -46.25% | $- | - | |
| Sep 15, 2026 | $4.88 | -44.89% | $- | - | |
| Sep 14, 2026 | $5.05 | -42.97% | $- | - |
Page 1 of 9